Providing coverage for biomarker testing.
HB 1062 mandates Washington health insurers cover biomarker testing to improve disease detection and personalized treatment access while potentially raising insurance costs.
HB 1062 mandates Washington health insurers cover biomarker testing to improve disease detection and personalized treatment access while potentially raising insurance costs.
WeVote — Public opinion
No community votes yet. Be the first to weigh in from the Vote tab.
Bill text & amendments